{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:54:27Z","timestamp":1783137267691,"version":"3.54.6"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cesarean section (CS) is the most frequently performed surgery in the United States. Compared to vaginal delivery, CS has a higher risk of maternal and neonatal mortality, morbidities, and complications, among which surgical site infection (SSI) is the most common. We aimed at evaluating the effectiveness of postoperative oral administration of cephalexin and metronidazole on SSI among obese women undergoing CS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a randomized, double-blind clinical trial comparing the prophylactic effect of oral cephalexin and metronidazole vs cephalexin and\u00a0placebo on SSI following CS among obese women. who had received preoperative prophylactic cephalosporin antibiotics. The study was conducted at the Ommolbanin Hospital, affiliated with Mashhad University of Medical Sciences from April 2019 to February 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>The participants were randomized into the intervention group (n\u2009=\u2009210) and the control group (n\u2009=\u2009210). At week-1 follow-up, the outcomes were significantly lower in the intervention group as compared to the control group in terms of fever (9% vs 19%,<jats:italic>p<\/jats:italic>\u2009=\u20090.003), abnormal discharge from the incision (serous: 8.6% vs 10.5%, purulent: 2.9% vs 16.7%,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), incision separation (1% vs 7.1%,<jats:italic>p<\/jats:italic>\u2009=\u20090.001), and cellulitis (4.8% vs 13.3%,<jats:italic>p<\/jats:italic>\u2009=\u20090.002). At week-2 follow-up, there were no patients in the intervention group with fever, abnormal discharge from the incision, incision separation, or cellulitis and there was a statistically significant difference for fever, abnormal discharge from the incision, and incision separation between the two groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001,<jats:italic>p<\/jats:italic>\u2009=\u20090.001,<jats:italic>p<\/jats:italic>\u2009=\u20090.014, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Post-operative administration of cephalexin and metronidazole for 48-h post-cesarean delivery among obese women, in addition to the standard pre-operative prophylaxis, reduced the overall rate of surgical site infection and wound infection symptoms in a 2-week follow-up.<\/jats:p><jats:p><jats:italic>Trial registration<\/jats:italic>The study protocol was approved by the Iranian Registry of Clinical Trials (IRCTID: IRCT20200608047685N2) on 2021-03-15.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13756-022-01191-y","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:03:30Z","timestamp":1670249010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of postoperative oral administration of cephalexin and metronidazole on surgical site infection among obese women undergoing cesarean section: a randomized, double-blind, placebo-controlled, parallel-group study\u2014phase III"],"prefix":"10.1186","volume":"11","clinical-trial-number":[{"clinical-trial-number":"irct20200608047685n2","registry":"10.18810\/irct"}],"author":[{"given":"Fatemeh","family":"Tara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-3922","authenticated-orcid":false,"given":"Sina","family":"Danesteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-6764","authenticated-orcid":false,"given":"Kiarash Roustai","family":"Geraylow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-5047","authenticated-orcid":false,"given":"AmirAli","family":"Moodi Ghalibaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-2203","authenticated-orcid":false,"given":"Somayeh","family":"Moeindarbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"1191_CR1","unstructured":"Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. National Vital Statistics Reports. 2019."},{"issue":"5","key":"1191_CR2","first-page":"545","volume":"43","author":"S Azami-Aghdash","year":"2014","unstructured":"Azami-Aghdash S, Ghojazadeh M, Dehdilani N, Mohammadi M, Asl Amin Abad R. Prevalence and causes of cesarean section in iran: systematic review and meta-analysis. Iran J Public Health. 2014;43(5):545\u201355.","journal-title":"Iran J Public Health"},{"issue":"5","key":"1191_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/1471-0528.13526","volume":"123","author":"AP Betr\u00e1n","year":"2016","unstructured":"Betr\u00e1n AP, Torloni MR, Zhang J-J, G\u00fclmezoglu A, Aleem H, Althabe F, et al. WHO statement on caesarean section rates. BJOG. 2016;123(5):667.","journal-title":"BJOG"},{"issue":"11","key":"1191_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1471-0528.2012.03452.x","volume":"119","author":"C Wloch","year":"2012","unstructured":"Wloch C, Wilson J, Lamagni T, Harrington P, Charlett A, Sheridan E. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG. 2012;119(11):1324\u201333.","journal-title":"BJOG"},{"issue":"12","key":"1191_CR5","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.midw.2012.12.012","volume":"29","author":"V Anderson","year":"2013","unstructured":"Anderson V, Chaboyer W, Gillespie B. The relationship between obesity and surgical site infections in women undergoing caesarean sections: an integrative review. Midwifery. 2013;29(12):1331\u20138.","journal-title":"Midwifery"},{"issue":"9","key":"1191_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/00016340701515225","volume":"86","author":"HK Op\u00f8ien","year":"2007","unstructured":"Op\u00f8ien HK, Valb\u00f8 A, Grinde-Andersen A, Walberg M. Post-cesarean surgical site infections according to CDC standards: rates and risk factors: a prospective cohort study. Acta Obstet Gynecol Scand. 2007;86(9):1097\u2013102.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"5","key":"1191_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/01443615.2017.1394281","volume":"38","author":"RC Pierson","year":"2018","unstructured":"Pierson RC, Scott NP, Briscoe KE, Haas DM. A review of post-caesarean infectious morbidity: how to prevent and treat. J Obstet Gynaecol. 2018;38(5):591\u20137.","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"1191_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajic.2018.07.023","volume":"47","author":"KB Saeed","year":"2019","unstructured":"Saeed KB, Corcoran P, O\u2019Riordan M, Greene RA. Risk factors for surgical site infection after cesarean delivery: a case-control study. Am J Infect Control. 2019;47(2):164\u20139.","journal-title":"Am J Infect Control"},{"issue":"8","key":"1191_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1086\/655435","volume":"31","author":"MA Olsen","year":"2010","unstructured":"Olsen MA, Butler AM, Willers DM, Gross GA, Fraser VJ. Comparison of costs of surgical site infection and endometritis after cesarean delivery using claims and medical record data. Infect Control Hosp Epidemiol. 2010;31(8):872\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1191_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40748-017-0051-3","volume":"3","author":"T Kawakita","year":"2017","unstructured":"Kawakita T, Landy HJ. Surgical site infections after cesarean delivery: epidemiology, prevention and treatment. Matern Health Neonatol Perinatol. 2017;3(1):1\u20139.","journal-title":"Matern Health Neonatol Perinatol"},{"key":"1191_CR11","first-page":"Cd009516","volume":"12","author":"AD Mackeen","year":"2014","unstructured":"Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev. 2014;12:Cd009516.","journal-title":"Cochrane Database Syst Rev."},{"issue":"12","key":"1191_CR12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archsurg.2011.725","volume":"146","author":"A Witt","year":"2011","unstructured":"Witt A, D\u00f6ner M, Petricevic L, Berger A, Germann P, Heinze G, et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double-blind, prospective, randomized. Placebo-Control Trial Arch Surg. 2011;146(12):1404\u20139.","journal-title":"Placebo-Control Trial Arch Surg"},{"issue":"11","key":"1191_CR13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jama.2017.10567","volume":"318","author":"AM Valent","year":"2017","unstructured":"Valent AM, DeArmond C, Houston JM, Reddy S, Masters HR, Gold A, et al. Effect of post-cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: a randomized clinical trial. JAMA. 2017;318(11):1026\u201334.","journal-title":"JAMA"},{"issue":"11","key":"1191_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jama.2017.10535","volume":"318","author":"DP Calfee","year":"2017","unstructured":"Calfee DP, Gr\u00fcnebaum A. Postoperative antimicrobial prophylaxis following cesarean delivery in obese women: An exception to the rule? JAMA. 2017;318(11):1012\u20133.","journal-title":"JAMA"},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijoa.2019.08.007","volume":"42","author":"SE Douville","year":"2020","unstructured":"Douville SE, Callaway LK, Amoako A, Roberts JA, Eley VA. Reducing post-caesarean delivery surgical site infections: a narrative review. Int J Obstet Anesth. 2020;42:76\u201386.","journal-title":"Int J Obstet Anesth"},{"key":"1191_CR16","unstructured":"Vasilyevich MD, Arkadievich SI, Petrenko AP, Protsenko D, Kulikov A, Punj J. Post caesarean surgical wound infection in obese patients: an open prospective cohort study. Indian Obstetrics Gynaecol. 2019;9(3)."},{"key":"1191_CR17","doi-asserted-by":"crossref","unstructured":"Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database System Rev. 2014(10).","DOI":"10.1002\/14651858.CD007482.pub3"},{"key":"1191_CR18","unstructured":"Sabila NM, Rosa EM. The effectiveness of the use of antibiotics prophylaxis in prevention of surgical site infection in caesarean section. Turk J Physiother Rehabil 32:3."},{"issue":"4","key":"1191_CR19","doi-asserted-by":"publisher","first-page":"416.e1-.44","DOI":"10.1016\/j.ajog.2018.01.016","volume":"218","author":"KE Fay","year":"2018","unstructured":"Fay KE, Yee L. Applying surgical antimicrobial standards in cesarean deliveries. Am J Obstet Gynecol. 2018;218(4):416.e1-.44.","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"1191_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/ajo.12755","volume":"58","author":"SM Scheck","year":"2018","unstructured":"Scheck SM, Blackmore T, Maharaj D, Langdana F, Elder RE. Caesarean section wound infection surveillance: information for action. Aust N Z J Obstet Gynaecol. 2018;58(5):518\u201324.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"1191_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/dkt444","volume":"69","author":"MJ Brill","year":"2014","unstructured":"Brill MJ, Houwink AP, Schmidt S, Van Dongen EP, Hazebroek EJ, van Ramshorst B, et al. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. J Antimicrob Chemother. 2014;69(3):715\u201323.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1191_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1089\/sur.2019.354","volume":"22","author":"GT Talbot","year":"2020","unstructured":"Talbot GT, Maxwell RA, Griffiths KM, Polenakovik HM, Galloway ML, Yaklic JL. A risk-stratified peri-operative protocol for reducing surgical site infection after cesarean delivery. Surg Infect. 2020;22(4):409\u201314.","journal-title":"Surg Infect"},{"issue":"10","key":"1191_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/01.SMJ.0000060570.51934.14","volume":"96","author":"NL Meyer","year":"2003","unstructured":"Meyer NL, Hosier KV, Scott K, Lipscomb GH. Cefazolin versus cefazolin plus metronidazole for antibiotic prophylaxis at cesarean section. South Med J. 2003;96(10):992\u20135.","journal-title":"South Med J"},{"key":"1191_CR24","volume-title":"Williams obstetrics","author":"FG Cunningham","year":"2014","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS. Williams obstetrics. New York: Mcgraw-hill; 2014."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01191-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T23:00:14Z","timestamp":1728514814000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01191-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01191-y","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"27 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The method has been approved in terms of compliance with scientific standards and ethical standards of evaluation. All methods were performed in accordance with the relevant guidelines and regulations. The Organizational Ethics Committee of Mashhad University of Medical Sciences, Mashhad, Iran, has also approved it. The registered ethical number is IR.MUMS.MEDICAL.REC.1397.733. Patients filled out a written informed consent before participating in the study. Also, no additional costs have been imposed on patients for this study, and patients have been studied during their treatment-diagnostic process. Also, the study protocol was approved by the Iranian Registry of Clinical Trials (IRCTID: IRCT20200608047685N2) on 2021-03-15.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}